MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review
Journal of Infection and Public Health2022Vol. 15(7), pp. 788–799
Citations Over TimeTop 10% of 2022 papers
Jivan Qasim Ahmed, Sazan Qadir Maulud, Manish Dhawan, Priyanka Choudhary, Om Prakash Choudhary, Prasun K. Jalal, Rezhna Kheder Ali, Gahin Abdulraheem Tayib, Dlshad Abdullah Hasan
Abstract
This review summarizes several studies revealing the involvement of miRNAs in diverse and complex processes during the infection process of SARS-CoV-2. The miRNAs can substantially reduce the viral load by degradation of viral RNA and reduced expression of ACE2 receptors, besides mitigating the deleterious consequences of the exaggerated secretion of cytokines. Extensive investigations need to be done by the scientific community to utilize the miRNA based strategies for the development of effective therapeutic targets against the COVID-19.
Related Papers
- → ПОПУЛЯЦИОННЫЙ ИММУНИТЕТ К ВИРУСУ SARS-CoV-2 СРЕДИ НАСЕЛЕНИЯ САНКТ-ПЕТЕРБУРГА В АКТИВНУЮ ФАЗУ ЭПИДЕМИИ COVID-19(2020)12 cited
- → ОПЫТ ОЦЕНКИ ПОПУЛЯЦИОНОГО ИММУНИТЕТА К SARS-CoV-2 СРЕДИ НАСЕЛЕНИЯ ЛЕНИНГРАДСКОЙ ОБЛАСТИ В ПЕРИОД ЭПИДЕМИИ COVID-19(2020)7 cited
- → Перинатальные последствия COVID-19 (SARS-CoV-2): обзор литературы (часть I)(2022)3 cited
- → ОПЫТ ИССЛЕДОВАНИЯ СЕРОПРЕВАЛЕНТНОСТИ К ВИРУСУ SARS-CoV-2 НАСЕЛЕНИЯ ИРКУТСКОЙ ОБЛАСТИ В ПЕРИОД ВСПЫШКИ COVID-19(2020)2 cited
- → Особенности сахароснижающей фармакотерапии у пациентов с SARS-CoV-2 (COVID-19)(2021)